• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    UK Fertility Services Market

    ID: MRFR/HC/43234-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    UK Fertility Services Market Research Report By Underlying Cause (Male Infertility, Female Infertility) and By Treatment Type (ART, Infertility Drugs)-Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    UK Fertility Services Market Infographic
    Purchase Options

    UK Fertility Services Market Summary

    The United Kingdom UK Fertility Services market is poised for substantial growth, expanding from 1.94 USD Billion in 2024 to 5.94 USD Billion by 2035.

    Key Market Trends & Highlights

    UK Fertility Services Key Trends and Highlights

    • The market is projected to grow at a compound annual growth rate of 10.71% from 2025 to 2035.
    • By 2035, the market value is expected to reach 5.94 USD Billion, indicating a robust upward trajectory.
    • In 2024, the market is valued at 1.94 USD Billion, reflecting the increasing demand for fertility services in the UK.
    • Growing adoption of assisted reproductive technologies due to rising infertility rates is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.94 (USD Billion)
    2035 Market Size 5.94 (USD Billion)
    CAGR (2025-2035) 10.71%

    Major Players

    The Fertility Partnership, Liverpool Women's Hospital, Fertility Associates, Queen Mary University Hospital, St Mary’s Hospital, Hammersmith Hospital, Luton and Dunstable University Hospital, Care Fertility, IVF England, Manchester Fertility, City Fertility, Bourn Hall Clinic, Addenbrooke's Hospital, Newlife Fertility

    UK Fertility Services Market Trends

    Numerous causes are driving numerous significant changes in the UK fertility services market at the moment. The public's growing knowledge about and acceptance of fertility treatments is one major factor propelling the industry. The demand for IVF and other assisted reproductive technologies is rising as more people and couples are talking openly about reproductive health concerns. Furthermore, new developments in medical technology and methods, such as egg freezing and preimplantation genetic testing, are increasing the success rates of reproductive treatments and drawing in more clients.

    Opportunities to investigate have increased recently in the UK, particularly with regard to the use of online consultations and telemedicine in fertility treatments. Since many patients prefer remote consultations in the aftermath of the COVID-19 outbreak, this tendency has become more pertinent. With more UK clinics embracing this digital revolution, fertility services are now more widely available across a range of geographic areas. This industry is also expected to flourish as a result of the government's emphasis on innovative research and dedication to promoting public health programs.

    The emphasis on individualized treatment regimens is another significant development in the UK. In order to improve results, clinics are now taking a more customized approach to reproductive care, taking into account variables including a couple's age, medical history, and genetic heritage. This individualized approach has become a significant aspect of patient attraction in the UK Fertility Services Market. Furthermore, social factors such as the rise in delayed parenthood are evident, prompting a growing segment of the population to seek fertility services at later ages, thus influencing market dynamics.

    Market Segment Insights

    Fertility Services Market Underlying Cause Insights

    The UK Fertility Services Market exhibits significant traction within the Underlying Cause segment, which encompasses both Male Infertility and Female Infertility. According to various healthcare data sources, male infertility accounts for approximately 30%-40% of infertility cases in the UK, underscoring its importance in the overall fertility landscape. Factors contributing to male infertility include hormonal imbalances, genetic issues, and lifestyle choices, which have been observed to increase in prevalence due to dietary habits and environmental exposures.

    Meanwhile, female infertility also represents a crucial aspect of the market, with conditions such as polycystic ovary syndrome (PCOS), endometriosis, and age-related fertility decline significantly impacting women’s reproductive health.

    Recent statistics illustrate that an increasing number of women in the UK are opting to postpone childbearing for personal or career-related reasons, leading to a rise in infertility issues associated with advanced maternal age. Both segments are driven by a combination of medical advancements and public awareness that encourages couples to seek fertility services earlier. Additionally, the growing influence of technological innovations in diagnostic testing and treatment options has propelled market growth in this sector.

    The expanding accessibility of assisted reproductive technologies, such as in vitro fertilization (IVF), has positioned the UK as a leader in fertility treatments, attracting not only domestic patients but also those from abroad seeking high-quality services.

    The integration of mental health support and holistic approaches within fertility services is further shaping the landscape as awareness grows about the emotional and psychological impacts of infertility challenges. This evolving market dynamic presents opportunities for practitioners to incorporate comprehensive care plans that address both physical and emotional aspects, thus enhancing patient experiences. With ongoing improvements in healthcare policies and increased investment in reproductive health, the Underlying Cause segment of the UK Fertility Services Market is poised for sustained growth, offering crucial solutions for couples facing infertility challenges.

    Fertility Services Market Treatment Type Insights

    The UK Fertility Services Market has seen substantial growth, driven by various treatment types, including Assisted Reproductive Technology (ART) and infertility drugs. ART is a prominent area within the market, encompassing techniques such as in vitro fertilization (IVF), which has become increasingly sought after due to rising infertility rates and changing societal norms around family planning. Infertility drugs also play a critical role, offering effective treatment options for individuals and couples facing challenges with conception.

    The demand for these treatments reflects a growing awareness and acceptance of fertility services in the UK, contributing to significant advancements in medical technology and practices.

    Furthermore, the UK government's commitment to improving healthcare access has created opportunities for service growth, thus ensuring better support for patients. As a result, the UK Fertility Services Market segmentation around Treatment Type not only meets the needs of various demographics but also adapts to ongoing trends such as personalized medicine, with a focus on quality and efficacy, both ART and infertility drugs continue to be essential components in helping individuals achieve their reproductive goals, ultimately shaping the future of fertility services in the market.

    Get more detailed insights about UK Fertility Services Market

    Key Players and Competitive Insights

    The UK Fertility Services Market is a dynamic and rapidly evolving sector characterized by a diverse array of services aimed at assisting couples and individuals seeking to conceive. With an increasing awareness of fertility issues, advancements in medical technology, and a growing acceptance of assisted reproductive technologies, the market has witnessed significant growth in recent years. The competitive landscape is marked by numerous specialized clinics and hospitals, each striving to offer unique services that cater to the varying needs of patients.

    Factors such as regulatory frameworks, technological innovation, and patient satisfaction are pivotal in shaping the competitive strategies of key players in this market. Companies are increasingly focusing on enhancing service quality, expanding their offerings, and optimizing patient care to gain a competitive edge.

    The Fertility Partnership has established itself as a significant player within the UK Fertility Services Market, renowned for providing comprehensive fertility solutions. The strength of The Fertility Partnership lies in its emphasis on personalized care, robust clinical outcomes, and a commitment to utilizing advanced technology in reproductive medicine. The company has garnered a solid reputation for its dedicated team of medical professionals who focus on delivering individualized treatment plans tailored to each patient's unique circumstances.

    This patient-centric approach has facilitated The Fertility Partnership's growth and bolstered its presence across multiple locations in the UK, enhancing accessibility for those seeking fertility assistance. By focusing on quality care, the organization has developed a loyal patient base while also contributing to awareness and education about fertility challenges.

    Liverpool Women's Hospital plays a pivotal role in the UK Fertility Services Market, being well-regarded for its comprehensive range of fertility treatments and services. The hospital is known for its state-of-the-art facilities and experienced staff, offering services such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and egg freezing. Liverpool Women's Hospital's strength lies in its commitment to research and innovation, frequently collaborating with leading institutions to push the boundaries of reproductive medicine.

    The hospital's reputation is further strengthened by its focus on patient care and positive clinical outcomes. Recently, Liverpool Women's Hospital has engaged in strategic partnerships and collaborations aimed at enhancing its service offerings, which may include mergers with other healthcare providers to expand its capabilities in the fertility domain. This proactive approach ensures that Liverpool Women's Hospital remains a vital contributor to the UK Fertility Services Market, fostering advancements in infertility treatments and improving patient options throughout the region.

    Key Companies in the UK Fertility Services Market market include

    Industry Developments

    The UK Fertility Services Market has seen notable developments recently, reflecting advancements and shifts within the sector. In October 2023, The Fertility Partnership announced an expansion of its services to accommodate the increasing demand for assisted reproductive technologies, indicating a positive trend in service uptake. Liverpool Women's Hospital and St Mary’s Hospital have reported improvements in patient outcomes due to the introduction of innovative fertility treatments over the last two years. Additionally, Care Fertility and IVF England are experiencing steady growth, supported by a rise in public awareness regarding fertility treatment options.

    Notably, in September 2023, Manchester Fertility and City Fertility engaged in a collaborative project aimed at integrating advanced techniques to enhance patient experiences.

    The UK government has supported these advancements by increasing funding for fertility research, which has stimulated market growth. While no recent mergers or acquisitions involving the specified companies have been publicly reported, the overall market valuation reflects a stronger position due to heightened demand and evolving treatment methodologies. This surge is driven by changing societal attitudes towards fertility, fostering a conducive environment for both patients and providers within the UK Fertility Services landscape.

    Market Segmentation

    Fertility Services Market Treatment Type Outlook

    • ART
    • Infertility Drugs

    Fertility Services Market Treatment Type Outlook 

    • ART
    • Infertility Drugs

    Fertility Services Market Underlying Cause Outlook

    • Male Infertility
    • Female Infertility

    Report Scope

     
    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 1.74(USD Billion)
    MARKET SIZE 2024 1.94(USD Billion)
    MARKET SIZE 2035 5.94(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 10.728% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED The Fertility Partnership, Liverpool Women's Hospital, Fertility Associates, Queen Mary University Hospital, St Mary’s Hospital, Hammersmith Hospital, Luton and Dunstable University Hospital, Care Fertility, IVF England, Manchester Fertility, City Fertility, Bourn Hall Clinic, Addenbrooke's Hospital, Newlife Fertility
    SEGMENTS COVERED Underlying Cause, Treatment Type
    KEY MARKET OPPORTUNITIES Increased demand for IVF treatments, Expansion of telemedicine for consultations, Rising awareness of fertility preservation, Growth in male fertility services, Development of personalized treatment plans
    KEY MARKET DYNAMICS rising infertility rates, increasing awareness and education, advancements in reproductive technology, government funding and regulations, growing demand for IVF services
    COUNTRIES COVERED UK

    FAQs

    What is the expected market size of the UK Fertility Services Market in 2024?

    The UK Fertility Services Market is expected to be valued at 1.94 billion USD in 2024.

    What is the projected market size for the UK Fertility Services Market by 2035?

    By 2035, the market is projected to reach a value of 5.94 billion USD.

    What is the expected compound annual growth rate (CAGR) for the UK Fertility Services Market from 2025 to 2035?

    The expected CAGR for the market from 2025 to 2035 is 10.728 percent.

    Which segment of the market has a higher projected value in 2024, male infertility or female infertility?

    In 2024, the female infertility segment is projected to be valued at 1.26 billion USD, compared to 0.68 billion USD for male infertility.

    What will be the market value for male infertility services by 2035?

    The male infertility segment is expected to reach a value of 2.05 billion USD by 2035.

    What will be the projected market value for female infertility services by 2035?

    By 2035, the market value for female infertility services is anticipated to be 3.89 billion USD.

    Who are some of the key players in the UK Fertility Services Market?

    Key players in the market include The Fertility Partnership, Liverpool Women's Hospital, and Care Fertility among others.

    What are the main drivers contributing to the growth of the UK Fertility Services Market?

    Key growth drivers include increasing awareness of fertility treatments and advancements in reproductive technologies.

    What is the expected market growth rate for the UK Fertility Services Market across the forecast period?

    The market is expected to grow significantly at a rate of 10.728 percent from 2025 to 2035.

    Is there a significant demand for fertility services in specific regions of the UK?

    Yes, there is a notable demand for fertility services in urban areas, reflecting higher access to specialized care.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials